32469-24-2Relevant articles and documents
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins
Xu, Jun,Lee, Steve Seung-Young,Seo, Howon,Pang, Liang,Jun, Yearin,Zhang, Ruo-Yu,Zhang, Zhong-Yin,Kim, Pilhan,Lee, Wooin,Kron, Stephen J.,Yeo, Yoon
, (2018)
Current nanoparticle (NP) drug carriers mostly depend on the enhanced permeability and retention (EPR) effect for selective drug delivery to solid tumors. However, in the absence of a persistent EPR effect, the peritumoral endothelium can function as an a
QUINIC ACID-MODIFIED NANOPARTICLES AND USES THEREOF
-
Page/Page column 0112; 0116; 0117, (2018/12/03)
The present invention generally relates to targeted nanoparticle delivery to E-selectin- or P-selectin-positive cells or tissues. In particular, this invention discloses a method for preparing quinic acid-modified nanoparticles for targeted drug delivery
Synthesis and biological evaluation of quinic acid derivatives as anti-inflammatory agents
Zeng, Kui,Thompson, Karin Emmons,Yates, Charles R.,Miller, Duane D.
body text, p. 5458 - 5460 (2010/08/04)
Quinic acid (QA) esters found in hot water extracts of Uncaria tomentosa (a.k.a. cat's claw) exert anti-inflammatory activity through mechanisms involving inhibition of the pro-inflammatory transcription factor nuclear factor kappa B (NF-κB). Herein, we d